arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

FITLIFE BRANDS, INC.

FTLF
$9.35 ▲ +0.20 (+2.19%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
71
Health
Good
Bullish
auto_awesome

Analytical Summary

FITLIFE BRANDS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $87.8M
Dividend Yield
Revenue Growth 64.6%
Op. Margin 12.6%
ROIC 5.1%
FCF / Share $0.39
Trailing P/E 44.5x
Price / Book 1.9x
FCF Yield 4.1%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$26.55M
↑ +64.6%
Net Income Profit after all expenses
$1.95M
↑ +11.6%
Operating Margin Operating profit as % of sales
12.6%
↑ +4.6% 62th
FCF / Share Free cash flow per share
$0.39
↑ +46.3%
Long-Term Debt Long-term obligations
$46.46M
↑ +635.0%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
60
Returns
79
Financial Health
75
Cash Quality
72

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters